2023年儿童重症肺炎支原体肺炎所致坏死性肺炎危险因素分析

doi:10.19871/j.cnki.xfcrbzz.2024.01.001

摘要/Abstract

摘要： 目的分析总结2023年儿童重症肺炎支原体肺炎所致坏死性肺炎的临床表现及胸部影像特征,并探讨发生坏死性肺炎的危险因素。方法收集2023年9月至11月深圳市儿童医院收治的50例重症肺炎支原体肺炎患儿的临床和胸部CT平扫及增强检查的资料,依据肺实质是否合并坏死,分坏死性肺炎组（28例）和非坏死性肺炎组（22例）。比较两组临床及影像学特点,将单因素分析中差异有统计学意义的指标进行多因素Logistic回归分析,并采用ROC曲线分析不同指标及联合指标的诊断效能。结果 50例患儿中男25例,女25例,平均年龄（6.56±3.13）岁。6例（12.00%）伴基础疾病。两肺多叶多段受累,部分楔形实变、支气管壁增厚,29例(58.00%)伴少量胸腔积液,肺门淋巴结肿大44例（88.00%）,肺实质坏死28例（56.00%）,典型坏死性肺空洞3例。所有患儿最终均好转出院。坏死性肺炎组和非坏死性肺炎组患儿性别、年龄、低氧血症、高热、C反应蛋白水平差异无统计学意义（P>0.05）。坏死性肺炎组患儿住院时间,D-二聚体、乳酸脱氢酶（lactate dehydrogenase,LDH）、谷丙转氨酶（alanine aminotransferase,ALT）水平及胸腔积液比例均高于非坏死性肺炎组,差异有统计学意义（P< 0.05）。多因素Logistic回归分析,LDH升高（OR=1.007,95%CI 1.001~1.013）和胸腔积液（OR=35.060,95%CI 4.523~271.777）是重症肺炎支原体肺炎患儿发生坏死性肺炎的独立危险因素。LDH和胸腔积液联合预测坏死性肺炎的敏感度为0.778,特异度为0.773,曲线下面积为0.852（95%CI 0.746~0.958）。结论重症肺炎支原体肺炎患儿如出现胸腔积液、LDH明显升高,应注意合并坏死性肺炎的可能,尽早识别并进行有效的临床干预。

关键词: 肺炎支原体, 坏死性肺炎, 计算机断层扫描, 胸腔积液, 乳酸脱氢酶, 儿童

Abstract: Objective To analyze and summarize the clinical manifestations and chest imaging features of necrotizing pneumonia caused by severe mycoplasma pneumoniae pneumonia in 2023, and to identify risk factors for necrotizing pneumonia. Method The clinical data and radiology data were collected on 50 children with severe mycoplasma pneumoniae pneumonia treated in Shenzhen Children's Hospital from September to November 2023. Children were examined with the chest CT scan and enhancement, and were divided into necrotizing and non-necrotizing pneumonia groups based on the enhancement of the lung parenchyma with or without necrosis. Clinical and radiology features were compared between two groups. Multivariate Logistic regression analysis was applied to analyze the indexes with significant differences in the univariate analysis. The ROC curve was used to analyze the diagnostic efficiency of different indicators and combined indicators. Result There were 25 males and 25 females among 50 children with a mean age of (6.56±3.13) years. Six cases (12.00%) had underlying diseases. Multiple lobes and segments of both lungs were involved, with partial wedge-shaped consolidation and bronchial wall thickening. Twenty-nine cases (58.00%) had a small amount of pleural effusion, with hilar lymph node enlargement in 44 cases (88.00%), pulmonary parenchyma necrosis in 28 cases (56.00%) and typical necrotizing cavities in 3 cases. All patients recovered and discharged. There was no significant difference in sex, age, hypoxemia, high fever or C-reactive protein between these two groups (P>0.05). The median hospitalization days, D-dimer, actate dehydrogenase (LDH) , alanine aminotransferase (ALT) and pleural effusion in necrotizing pneumonia group were significantly higher than those in the non-necrotizing pneumonia group (P<0.05). Multivariate Logistics regression analysis showed that LDH (OR=1.007, 95%CI 1.001-1.013) and pleural effusion(OR=35.060, 95%CI 4.523-271.777) were independent predictors of necrotizing pneumonia in children with severe mycoplasma pneumoniae pneumonia. When LDH and pleural effusion were used for joint prediction, the sensitivity was 0.778, the specificity was 0.773, and the area under the curve was 0.852 (95%CI 0.746-0.958). Conclusion Children with severe mycoplasma pneumoniae who present with pleural effusions and apparently elevated LDH should be alerted to the possibility of combination with necrotizing pneumonia. Early recognition and effective clinical intervention should be performed.

Key words: Mycoplasma pneumoniae, Necrotizing pneumonia, Computed tomography, Pleural effussion, Lactate dehydrogenase, Children

中图分类号:

黎耀文, 林洁琼, 范绮梦, 熊海芮, 曾洪武. 2023年儿童重症肺炎支原体肺炎所致坏死性肺炎危险因素分析[J]. 新发传染病电子杂志, 2024, 9(1): 1-6.

Li Yaowen, Lin Jieqiong, Fan Qimeng, Xiong Hairui, Zeng Hongwu. Analysis of risk factors for necrotizing pneumonia caused by severe mycoplasma pneumoniae pneumonia in children in 2023[J]. Electronic Journal of Emerging Infectious Diseases, 2024, 9(1): 1-6.

参考文献

[1] 史大伟, 刘玲, 赵萌萌, 等. 肺炎支原体肺炎患儿支气管肺泡灌洗液中肺炎支原体耐药基因和13种病原检测结果分析[J]. 中华实用儿科临床杂志, 2022, 37(12):893-896.
[2] CHEN J, QI X, YIN Y, et al.Effects of minocycline on macrolide-unresponsive Mycoplasma pneumoniae pneumonia in children: a single-center retrospective study[J]. Transl Pediatr, 2021, 10(11):2997-3004.
[3] BAE E, KIM Y J, KANG H M, et al.Macrolide versus Non-Macrolide in Combination with Steroids for the Treatment of Lobar or Segmental Mycoplasma pneumoniae Pneumonia Unresponsive to Initial Macrolide Monotherapy[J]. Antibiotics (Basel), 2022, 11(9):1233
[4] 王秀芳, 李伟霞, 张艳丽,等. 儿童肺炎支原体坏死性肺炎预测指标研究[J]. 临床儿科杂志, 2019, 37(6):409-412.
[5] 王瑞珠, 席艳丽, 郭斌, 等. 儿童肺炎支原体感染致坏死性肺炎的影像特点及血CG反应蛋白,DG二聚体的评价[J]. 实用放射学杂志, 2019, 35(6):952-955,962.
[6] 曾洪武, 黄文献, 陈杰华, 等. 儿童坏死性肺炎的临床特点及胸部HRCT特征[J]. 放射学实践, 2018, 33(7):758-761.
[7] 刘帅帅, 马静, 张忠晓, 等. 增强CT对儿童坏死性肺炎的诊断价值[J]. 中华实用儿科临床杂志, 2021, 36(4):267-270.
[8] 国家卫生健康委员会. 儿童肺炎支原体肺炎诊疗指南(2023年版)[J]. 传染病信息, 2023, 36(4):291-297.
[9] 吴琰, 魏会平, 曹欣, 等. 儿童下呼吸道肺炎支原体感染流行特点分析[J/CD]. 新发传染病电子杂志, 2021, 6(4):336-338.
[10] DIAZ MH, BENITEZ AJ, WINCHELL JM.Investigations of Mycoplasma pneumoniae infections in the United States: trends in molecular typing and macrolide resistance from 2006 to 2013[J]. J Clin Microbiol, 2015, 53(1):124-130.
[11] 宣传司. 国家卫生健康委员会 2023 年 11 月 13 日新闻发布会文字实[EB/OL].(2023-11-13)[2023-12-17]. http://www.nhc.gov.cn/xcs/s3574/202311/0807e750e6cc4a81a22b6d881913cf5d.shtml.
[12] 周云连, 刘金荣, 易秋维, 等. 儿童坏死性肺炎病原学的多中心回顾性研究[J]. 中华儿科杂志, 2021, 59(8):658-664.
[13] HSIEH YC, HSUEH PR, LU CY, et al.Clinical manifestations and molecular epidemiology of necrotizing pneumonia and empyema caused by Streptococcus pneumoniae in children in Taiwan[J]. Clin Infect Dis, 2004, 38(6):830-835.
[14] SEO H, CHA SI, SHIN KM, et al.Focal necrotizing pneumonia is a distinct entity from lung abscess[J]. Respirology, 2013, 18(7):1095-1100.
[15] 陆权, 车大钿. 肺炎支原体性胸腔积液[J]. 中国实用儿科杂志, 2008, 23(4):241-244.
[16] 黄倩, 曾赛珍, 陈玲玲, 等. 36例儿童坏死性肺炎临床特征分析[J]. 中国小儿急救医学, 2023, 30(2):115-121.
[17] SPENCER DA, THOMAS MF.Necrotising pneumonia in children[J]. Paediatr Respir Rev, 2014, 15(3):240-245.
[18] ZHENG Y, HUA L, ZHAO Q, et al.The Level of D-Dimer Is Positively Correlated With the Severity of Mycoplasma pneumoniae Pneumonia in Children[J]. Front Cell Infect Microbiol, 2021, 11:687391.
[19] FOX JC, SZYJKOWSKI RS, SANDERSON SO, et al.Progressive cholestatic liver disease associated with clarithromycin treatment[J]. J Clin Pharmacol, 2002, 42(6):676-680.
[20] KIM KW, SUNG JJ, TCHAH H, et al.Hepatitis associated with Mycoplasma pneumoniae infection in Korean children: a prospective study[J]. Korean J Pediatr, 2015, 58(6): 211-217.
[21] ZHOU J, HE Z, MA S, et al.AST/ALT ratio as a significant predictor of the incidence risk of prostate cancer[J]. Cancer Med, 2020, 9(15):5672-5677.
[22] 李洪娜, 郭艳霞, 谢金霞, 等. 肺炎支原体肺炎患儿血清ALT、AST水平变化及其对预后的预测价值[J]. 山东医药, 2023, 63(23):55-57.
[23] JIN X, ZHU Y, ZHANG Y, et al.Assessment of levels of D-dimer and interferon-γ in pediatric patients with Mycoplasma pneumoniae pneumonia and its clinical implication[J]. Exp Ther Med, 2018, 16(6):5025-5030.